Butallylonal
From Wikipedia, the free encyclopedia
|
Butallylonal
|
|
| Systematic (IUPAC) name | |
| 5-sec-Butyl-5-(beta-bromoallyl)barbituric acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | ? |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Butallylonal is a barbiturate derivative invented in the 1920s[1]. It has sedative properties, and was used primarily as an anaesthetic in veterinary medicine. [2] Butallylonal is considered similar in effects to pentobarbital but is longer in action, being considered an intermediate-acting barbiturate rather than short-acting.
[edit] References
- ^ US patent 1739662
- ^ Mittmann U, Schmidt HD, Schmier J, Wirth RH. Hemorrhagic shock with fixed hypotension and with spontaneous recovery of blood pressure. A comparison of two shock models. Basic Research in Cardiology. 1976. 71(1):47-59
|
|||||

